EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
ALX Oncology Holdings Inc. (ALXO) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-17.93M |
|
-- |
|
-- |
|
$18.97M |
|
$-18.97M |
|
$1.04M |
|
$-17.93M |
|
$-17.93M |
|
$-17.93M |
|
$-17.93M |
|
$-17.93M |
|
$-17.93M |
|
$-18.97M |
|
$-18.95M |
|
104.57M |
|
104.57M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$145.56M |
|
$1.05M |
|
$32.76M |
|
$178.33M |
|
$20.18M |
|
$3.29M |
|
$6.80M |
|
$26.98M |
|
$151.35M |
|
$151.35M |
|
$151.35M |
|
134.54M |
|
| Cash Flow Statement Financials | |
$-18.65M |
|
$-105.04M |
|
$139.59M |
|
$16.44M |
|
$32.35M |
|
$15.91M |
|
$2.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.21 |
|
-- |
|
-- |
|
0.02 |
|
0.06 |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-18.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.85% |
|
-11.85% |
|
-10.05% |
|
-11.59% |
|
$1.12 |
|
$-0.18 |
|
$-0.18 |
|